Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Assisted Reproduction and Genetics
Published in: Journal of Assisted Reproduction and Genetics 8/2009

01-08-2009 | GENETICS

Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9-year experience

Prenatal diagnosis in FGFR3 gene

Authors: M. J. Trujillo-Tiebas, M. Fenollar-Cortés, I. Lorda-Sánchez, J. Díaz-Recasens, A. Carrillo Redondo, C. Ramos-Corrales, C. Ayuso

Published in: Journal of Assisted Reproduction and Genetics | Issue 8/2009

Login to get access

Abstract

Purpose

Prenatal diagnosis with ultrasound findings compatible with skeletal dysplasia due to FGFR3 mutations over a 9 year period in pregnancies and abortuses.

Methods

54 samples were studied. Aneuploidy studies were carried out on all samples. By sequencing analysis, we determined mutations for achondroplasia (ACH), hypochondroplasia (HCH), and type I and type II tanathophoric dysplasia (TD).

Results

2 chorionic villi samples had a G380R mutation due to a mother with ACH; 4 amniotic fluid samples with TDs in which the foetuses had micromelia plus hypoplastic thoraces; 5 samples from abortuses with TDs. Neither ACH nor HCH occurred in sporadic cases.

Conclusions

Molecular studies in ongoing pregnancies are indicated in cases with an affected parent, a family history with positive molecular studies (maternal anxiety), and when the US finding demonstrates micromelia with a hypoplastic thorax. A protocol for tissues of abortuses should include an X-ray, pathologic anatomy, and genetic studies.
Literature
1.
Spranger J. Bone dysplasia families. Pathol Immunpathol Res. 1988;7:76–80.CrossRef
2.
Keegan K, Johnson DE, Williams LT, Hayman MJ. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR3. Proc Acad Sci USA. 1991;88:1095–1099.CrossRef
3.
Keegan K, Rooke L, Hayman M, Spurr NK. The fibroblast growth factor receptor 3 gene (FGFR3) is assigned to human chromosome 4. Cytogenet Cell Genet. 1993;62:172–175. 12.CrossRefPubMed
4.
Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasia, Muenke craniosynostosis and Crouzon syndrome with acanthosis nigricans. Endocr Rev. 2000;21:23–39.CrossRefPubMed
5.
Orioli IM, Castila EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet. 1986;23:328–332.CrossRefPubMed
6.
Martínez-Frías ML, Cereijo A, Bermejo E, López M, Sánchez M, Golnalo C. Epidemiological aspects fo Mendelian syndromes in a Spanish population sample: I. autosomal dominant malformation syndromes. Am J Med Genet. 1991;38:622–625.CrossRefPubMed
7.
Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, et al. Thanatophoric dysplasia (types I and II) caused by distint mutations in fibroblast growth factor receptor 3. Nat Genet. 1995;9:321–328.CrossRefPubMed
8.
Tavormina PL, Bellus GA, Webster MK, Bamshad MJ, Fraley AE, McIntosh I, et al. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. Am J Hum Genet. 1999;64:722–731.CrossRefPubMed
9.
Stoll C, Dott B, Roth MP, Alembik Y. Birth prevalence rates of skeletal dysplasias. Clin Genet. 1989;35:88–92.PubMedCrossRef
10.
Rolf C, Nieschlag E. Reproductive functions, fertility and genetic risks of ageing men. Exp Clin Endocrinol Diabetes. 2001;109:68–74.CrossRefPubMed
11.
Wyrobeck AJ, Eskenazi B, Young S, Arnheim N, Tieman-Boege I, Jabs EW, et al. Advancing age has different effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies sperm. Proc Natl Aca Sci USA. 2006;103:9601–9606.CrossRef
12.
Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, et al. Mutations in the gene encoding fibroblast receptor growth factor receptor-3 in achondroplasia. Nature. 1994;371:252–254.CrossRefPubMed
13.
Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, et al. Mutations in the transmenbrane domain of FGFR3 cause the most common genetic form of dawrfism, achondroplasia. Cell. 1994;78:335–342.CrossRefPubMed
14.
Climent C, Lorda I, Urioste M, Gairi JM, Rodriguez JI, Rubio V. Acondroplasia: estudio molecular de 28 pacientes. Med Clin. 1998;110:492–494.
15.
Bellus GA, McIntosh I, Smith EA, Aylsworth AS, Kaitila I, Horton WA, et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet. 1995;10:357–359.CrossRefPubMed
16.
Rousseau F, Bonaventure J, Legeai-Mallet L, Schmidt H, Weissenbach J, Maroteaux P, et al. Clinical and genetic heterogeneity of hypochondroplasia. J Med Genet. 1996;33:749–752.CrossRefPubMed
17.
Parrilla BV, Leeth EA, Kambich MP, Chilis P, MacGregor S. Antenatal detection of skeletal dysplasias. J Ultrasound Med. 2003;22:255–258.
18.
Adinolfi M, Pertl B, Sherlock J. Rapid detection of aneuploidies by microsatellite and the quantitative fluorescent polymerase chain reaction. Prenat Diagn. 1997;17:1299–1311.CrossRefPubMed
19.
Wapner RJ, Sorokin Y, Thom EA, Jonhson F, Dudley DJ, Spong CT, et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol. 2006;195:633–642.CrossRefPubMed
20.
Trujillo-Tiebas MJ, Riveiro R, Queipo A, Vallespin E, Cantalapiedra D, Lorda-Sánchez I, et al. Gene Symbol: FGFR3. Hum Genet. 2004;115(4):348.
21.
Karadimas C, Sifakis S, Valsamopoulos P, Makatsoris C, Velissariou V, Nasioulas G, et al. Prenatal diagnosis of hypochondroplasia: report of two cases. Am J Med Genet Part A. 2006;140:998–1003.PubMed
22.
Gooding HC, Boehm K, Thompson RE, Hadley D, Francomano CA, Bowles BB. Issues sorrounding prenatal testing for achondroplasia. Prenat Diagn. 2002;22:933–940.CrossRefPubMed
23.
Camera G, Dodero D, De Pascale S. Prenatal diagnosis of thanatophoric dysplasia at 24 weeks. Am J Med Genet. 1984;18:39–43.CrossRefPubMed
24.
Elejalde BR, Elejalde MM. Thanatophoric dysplasia: fetal manifestations and prenatal diagnosis. Am J Med Genet. 1985;22:669–683.CrossRefPubMed
25.
Chen Ch-P, Chern S-R, Shih J-Ch, Wayseen W, Yeh L-F, Chang T-Y, et al. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia. Prenat Diagn. 2001;21:89–95.CrossRefPubMed
26.
Todros T, Massarenti I, Gaglioti P, Biolcati G, De Felice C. Fetal short femur length in the second trimester and the outcome of pregnancy. BJOG. 2004;111:83–85.CrossRefPubMed
27.
Modaff P, Horton VK, Pauli RM. Errors in the prenatal diagnosis of children with achondroplasia. Prenat Diagn. 1996;16:525–530.CrossRefPubMed
28.
Kataoka S, Sawai H, Yamada H, Kanazawa N, Koyama K, Nishimura G, et al. Radiographic and genetic diagnosis of sporadic hypochondroplasia early in the neonatal period. Prenat Diagn. 2004;24:45–49.CrossRefPubMed
29.
Ramalho C, Matias A, Brandão O, Montenegro N. Critical evaluation of elective termination of pregnancy in a tertiary fetal medicine center during 43 months: correlation of prenatal diagnosis findings and postmortem examination. Prenat Diagn. 2006;26:1084–1088.CrossRefPubMed
30.
Aslan H, Yldirim G, Ongut C, Ceylan Y. Termination of pregnancy for fetal anomaly. Int J Gynaecol Obstet. 2007;99:221–224.CrossRefPubMed
31.
Guillem P, Fabre B, Cans C, Robert-Gnansia E, Jouk PS. Trends in elective termination of pregnancy between 1989 and 2000 in French county (the Isère). Prenat Diagn. 2003;23:877–883.CrossRefPubMed
32.
Vaknin Z, Ben-Ami I, Reish O, Herman A, Maymon R. Fetal abnormalities leading to termination of singleton pregnancy: the 7-year experience of a single medical center. Prenat Diagn. 2006;26:938–943.CrossRefPubMed
33.
Orioli IM, Castilla EE, Scarano G, Mastroiacovo P. Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta. Am J Med Genet. 1995;50:209–217.CrossRef
34.
Wilkin DJ, Szabo JK, Cameron R, Henderson S, Bellus GA, Mack ML, et al. Mutation in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet. 1998;63:711–716.CrossRefPubMed
Metadata
Title
Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9-year experience
Prenatal diagnosis in FGFR3 gene
Authors
M. J. Trujillo-Tiebas
M. Fenollar-Cortés
I. Lorda-Sánchez
J. Díaz-Recasens
A. Carrillo Redondo
C. Ramos-Corrales
C. Ayuso
Publication date
01-08-2009
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 8/2009
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-009-9339-1

Other articles of this Issue 8/2009

Journal of Assisted Reproduction and Genetics 8/2009 Go to the issue

Assisted Reproduction

The influence of early cleavage on embryo developmental potential and IVF/ICSI outcome

Minireview

Antioxidants and sperm DNA damage: a clinical perspective

COMMENTARY

From the Editor

ORIGINAL ARTICLE

Blastocyst transfer and gender: IVF versus ICSI

Animal Experimentation in Assisted Reproduction

Development of a new method to preserve caprine cauda epididymal spermatozoa in-situ at -10°C with electrolyte free medium

CRYOPRESERVATION

Birth of a healthy male infant after transfer of vitrified-warmed blastocysts derived from intracytoplasmic sperm injection with vitrified-warmed oocytes and frozen-thawed spermatozoa